0 Commentaires
0 Parts
70 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
- Connectez-vous pour aimer, partager et commenter!
- Monoclonal Antibody Therapy Market Size Trends and ProjectionsThe Monoclonal Antibody Therapy Market is expected to reach USD 230.38 Bn by 2031 and was valued at USD 87.8 Bn in 2023 and will grow at a CAGR of 12.8% over the forecast period of 2024-2031.The Monoclonal Antibody Therapy Market is experiencing significant growth, driven by advancements in biotechnology and a rising prevalence of chronic diseases such as cancer, rheumatoid arthritis, and...0 Commentaires 0 Parts 149 Vue 0 Aperçu
- Monoclonal Antibody Therapy Market: Size, Growth, Segmentation, Analysis, Trends & Industry Forecast 2024-2031Mononucleosis Diagnostic Market Analysis The Mononucleosis Diagnostic Market size was estimated at USD 1.7 billion in 2022 and is expected to reach USD 3.2 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.6% during the forecast period from 2023 to 2030. Mononucleosis, caused by the Epstein-Barr virus (EBV), is a common viral infection that affects a large number of...0 Commentaires 0 Parts 156 Vue 0 Aperçu
- Global Monoclonal Antibody Therapy Market Outlook, Opportunity and Demand Analysis, Applications and Forecast 2024 to 2031Monoclonal Antibody Therapy Market Analysis The Monoclonal Antibody Therapy Market size was valued at USD 87.8 billion in 2023 and is expected to reach USD 230.38 billion by 2031, growing at a compound annual growth rate (CAGR) of 12.8% over the forecast period from 2024 to 2031. Monoclonal antibody therapy involves using laboratory-made antibodies that can bind to specific targets in the body,...0 Commentaires 0 Parts 157 Vue 0 Aperçu
- Monoclonal Antibody Therapy Market Analysis, Growth, Demand and Overview Forecast Research Report to 2031The global Monoclonal Antibody Therapy market, valued at USD 87.8 billion in 2023, is projected to witness substantial growth, reaching USD 230.38 billion by 2031. This growth represents a robust compound annual growth rate (CAGR) of 12.8% during the forecast period from 2024 to 2031. Monoclonal antibodies (mAbs) play a pivotal role in the treatment of various diseases, including...0 Commentaires 0 Parts 61 Vue 0 Aperçu